Patent foramen ovale

References

• Tsimikas S. Transcatheter closure of patent foramen ovale for migraine prophylaxis: hope or hype? J. Am. Coll. Health 45, 496–498 (2005).
   Google Scholar
• Schrader R. Indication and techniques of transcatheter closure of patent foramen ovale. J. Interv. Cardiol. 16, 543–551 (2003).
   PubMedGoogle Scholar
• •Reviews the indications and techniques of device closure of patent foramen ovale (PFO).
   Google Scholar
• Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin. Proc. 59, 17–20 (1984).
   PubMed Web of Science ®Google Scholar
• Webster MW, Chancellor AM, Smith HJ et al. Patent foramen ovale in young stroke patients. Lancet 2, 11–12 (1988).
   PubMed Web of Science ®Google Scholar
• Lechat P, Mas JL, Lascault G et al. Prevalence of patent foramen ovale in patients with stroke. N. Engl. J. Med. 318, 1148–1152 (1988).
   PubMed Web of Science ®Google Scholar
• Khairy P, O’Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann. Intern. Med. 139, 753–760 (2003).
   PubMed Web of Science ®Google Scholar
• •Systemic review of the comparison of device closure versus medical therapy of PFO.
   Google Scholar
• Di Tullio M, Sacco RL, Gopal A, Mohr JP, Homma S. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann. Intern. Med. 117, 461–465 (1992).
   PubMed Web of Science ®Google Scholar
• Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 55, 1172–1179 (2000).
   PubMed Web of Science ®Google Scholar
• Meier B, Lock JE. Contemporary management of patent foramen ovale. Circulation 107, 5–9 (2003).
   PubMed Web of Science ®Google Scholar
• •Reviews the contemporary management of PFO.
   Google Scholar
• Windecker S, Wahl A, Nedeltchev K et al. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J. Am. Coll. Health 44, 750–758 (2004).
   Google Scholar
• •Demonstrates that device closure of PFO is at least as effective as medical treatment for prevention of recurrent cerebrovascular events in cryptogenic stroke with PFO.
   Google Scholar
• Srivastava TN, Payment MF. Images in clinical medicine. Paradoxical embolism-thrombus in transit through a patent foramen ovale. N. Engl. J. Med. 337, 681 (1997).
   PubMedGoogle Scholar
• Falk V, Walther T, Krankenberg H, Mohr FW. Trapped thrombus in a patent foramen ovale. Thorac. Cardiovasc. Surg. 45, 90–92 (1997).
   PubMed Web of Science ®Google Scholar
• Kessel-Schaefer A, Lefkovits M, Zellweger MJ et al. Migrating thrombus trapped in a patent foramen ovale. Circulation 103, 1928 (2001).
   PubMed Web of Science ®Google Scholar
• Stone DA, Godard J, Corretti MC et al. Patent foramen ovale: association between the degree of shunt by contrast transesophageal echocardiography and the risk of future ischemic neurologic events. Am. Heart J. 131, 158–161 (1996).
   PubMed Web of Science ®Google Scholar
• Steiner MM, Di Tullio MR, Rundek T et al. Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. Stroke 29, 944–948 (1998).
   PubMed Web of Science ®Google Scholar
• Schuchlenz HW, Weihs W, Horner S, Quehenberger F. The association between the diameter of a patent foramen ovale and the risk of embolic cerebrovascular events. Am. J. Med. 109, 456–462 (2000).
   PubMed Web of Science ®Google Scholar
• Stollberger C, Slany J, Schuster I, Leitner H, Winkler WB, Karnik R. The prevalence of deep venous thrombosis in patients with suspected paradoxical embolism. Ann. Intern. Med. 119, 461–465 (1993).
   PubMed Web of Science ®Google Scholar
• Lethen H, Flachskampf FA, Schneider R et al. Frequency of deep vein thrombosis in patients with patent foramen ovale and ischemic stroke or transient ischemic attack. Am. J. Cardiol. 80, 1066–1069 (1997).
   PubMed Web of Science ®Google Scholar
• Cramer SC, Rordorf G, Maki JH et al. Increased pelvic vein thrombi in cryptogenic stroke: results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) study. Stroke 35, 46–50 (2004).
   PubMed Web of Science ®Google Scholar
• Agmon Y, Khandheria BK, Meissner I et al. Frequency of atrial septal aneurysms in patients with cerebral ischemic events. Circulation 99, 1942–1944 (1999).
   PubMed Web of Science ®Google Scholar
• Mas JL, Arquizan C, Lamy C et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N. Engl. J. Med. 345, 1740–1746 (2001).
   PubMed Web of Science ®Google Scholar
• Telman G, Kouperberg E, Sprecher E, Goldsher D, Yarnitsky D. Distribution of artificial cerebral microemboli in stroke patients with patent foramen ovale. Neurol. Res. 27, 109–111 (2005).
   PubMed Web of Science ®Google Scholar
• Wu LA, Malouf JF, Dearani JA et al. Patent foramen ovale in cryptogenic stroke: current understanding and management options. Arch. Intern. Med. 164, 950–956 (2004)
   PubMedGoogle Scholar
• Devuyst G, Piechowski-Jozwiak B, Karapanayiotides T et al. Controlled contrast transcranial Doppler and arterial blood gas analysis to quantify shunt through patent foramen ovale. Stroke 35, 859–863 (2004).
   Google Scholar
• Schuchlenz HW, Weihs W, Beitzke A, Stein JI, Gamillscheg A, Rehak P. Transesophageal echocardiography for quantifying size of patent foramen ovale in patients with cryptogenic cerebrovascular events. Stroke 33, 293–296 (2002).
   PubMedGoogle Scholar
• Hijazi ZM, Wang Z, Cao Q, Koenig P, Waight D, Lang R. Transcatheter closure of atrial septal defects and patent foramen ovale under intracardiac echocardiographic guidance: feasibility and comparison with transesophageal echocardiography. Cathet. Cardiovasc. Interv. 52, 194–199 (2001).
   PubMed Web of Science ®Google Scholar
• •Reports the experience of device closure of PFO under intracardiac echocardiographic guidance that eliminates the need of general anethesia.
   Google Scholar
• Landzberg MJ, Khairy P. Indications for the closure of patent foramen ovale. Heart 90, 219–224 (2004).
   PubMed Web of Science ®Google Scholar
• •Authors review the relationship of PFO and stroke and discuss the indications for device closure of PFO.
   Google Scholar
• Bridges ND, Hellenbrand W, Latson L, Filiano J, Newburger JW, Lock JE. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation 86, 1902–1908 (1992).
   PubMed Web of Science ®Google Scholar
• Meier B. Closure of patent foramen ovale: technique, pitfalls, complications, and follow-up. Heart 91, 444–448 (2005).
   PubMed Web of Science ®Google Scholar
• Reisman M, Christofferson RD, Jesurum J et al. Migraine headache relief after transcatheter closure of patent foramen ovale. J. Am. Coll. Health 45, 493–495 (2005).
   Google Scholar
• •Demonstrates that device closure of PFO results in complete resolution or marked reduction in frequency of migraine headache in patients with paradoxical cerebral embolism.
   Google Scholar
• Schwerzmann M, Wiher S, Nedeltchev K et al. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 62, 1399–1401 (2004).
   PubMed Web of Science ®Google Scholar